Gabriel Ling - 20 Nov 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Gabriel Ling
Issuer symbol
TOI
Transactions as of
20 Nov 2025
Transactions value $
$0
Form type
4
Filing time
24 Nov 2025, 17:23:29 UTC
Previous filing
20 Nov 2025
Next filing
01 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ling Gabriel Director C/O THE ONCOLOGY INSTITUTE OF HOPE, 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS /s/ Mark Hueppelsheuser, Attorney-in-Fact for Gabriel Ling 24 Nov 2025 0001945281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Award $0 +46.3K +18.5% $0.00 297K 20 Nov 2025 Direct F1
transaction TOI Common Stock Award $0 +37K +12.49% $0.00 334K 20 Nov 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date.
F2 . Represents restricted stock units that were fully vested upon grant.